GlobeNewswire Inc.··NaTonix Pharma to Showcase Commercial Portfolio at BIO-Europe Spring 2026
Tonix Pharmaceuticals CEO to present commercial CNS portfolio at BIO-Europe Spring 2026, showcasing TONMYA® fibromyalgia launch success with 1,500+ prescriptions since November 2025.
TNXPclinical trialsbiotechnology